Assessment of airway neutrophils by sputum colour: correlation with airways inflammation

R A Stockley, D Bayley, S L Hill, A T Hill, S Crooks, E J Campbell, R A Stockley, D Bayley, S L Hill, A T Hill, S Crooks, E J Campbell

Abstract

Background: Airway inflammation, with recruitment of neutrophils to the airway lumen, results in purulent secretions and a variety of potential adverse consequences for patients with chronic bronchitis and bronchiectasis. We hypothesised that gradations of sputum colour would correlate directly with the myeloperoxidase content of sputum and with various other indicators of the activity and consequences of bronchial diseases.

Methods: To test this hypothesis, we quantified sputum colour by reference to a sensitive nine point colour chart and correlated this assessment with indices of a number of inflammatory mediators in sputum.

Results: The results indicate that standardised visual measurements of sputum colour correlated strongly with myeloperoxidase, interleukin 8, leucocyte elastase (both activity and total quantity), sputum volume, protein leak, and secretory leucocyte proteinase inhibitor (p<0.001 for all). In addition, there was a strong direct correlation between leucocyte elastase and both myeloperoxidase (p<0.003) and sputum volume (p<0.001), but a strong negative correlation with secretory leucocyte proteinase inhibitor (p<0.001).

Conclusions: These results indicate that sputum colour graded visually relates to the activity of the underlying markers of bronchial inflammation. The results of this simple visual analysis of sputum provides guidance concerning underlying inflammation and its damaging potential. It also provides a useful scientific tool for improving the monitoring of chronic airways diseases and response to treatment.

References

    1. J Clin Invest. 1991 Sep;88(3):891-7
    1. Am Rev Respir Dis. 1992 Mar;145(3):675-9
    1. J Clin Invest. 1992 May;89(5):1478-84
    1. J Clin Invest. 1992 Oct;90(4):1296-301
    1. Blood. 1993 Jan 15;81(2):357-64
    1. Am J Respir Cell Mol Biol. 1993 Oct;9(4):455-62
    1. Am J Respir Cell Mol Biol. 1994 Dec;11(6):733-41
    1. Am J Physiol. 1994 Dec;267(6 Pt 1):L775-85
    1. Thorax. 1995 Apr;50(4):360-5
    1. J Cell Biol. 1995 Nov;131(3):775-89
    1. Thorax. 1996 Sep;51(9):914-8
    1. Am J Respir Crit Care Med. 1999 Dec;160(6):1968-75
    1. Chest. 2000 Jun;117(6):1638-45
    1. Am Rev Respir Dis. 1977 Mar;115(3):461-78
    1. Am Rev Respir Dis. 1977 Sep;116(3):469-75
    1. Methods Enzymol. 1977;46:208-16
    1. Infect Immun. 1979 Apr;24(1):188-93
    1. Am Rev Respir Dis. 1979 Nov;120(5):1081-6
    1. Nature. 1980 Jul 17;286(5770):264-5
    1. Hoppe Seylers Z Physiol Chem. 1984 Apr;365(4):503-10
    1. Thorax. 1984 Jun;39(6):408-13
    1. Thorax. 1984 Sep;39(9):663-7
    1. Am Rev Respir Dis. 1985 Aug;132(2):362-6
    1. Thorax. 1986 Jul;41(7):559-65
    1. Ann Intern Med. 1987 Feb;106(2):196-204
    1. Clin Chest Med. 1987 Sep;8(3):481-94
    1. Chest. 1989 Jan;95(1):190-5
    1. Biol Chem Hoppe Seyler. 1988 Sep;369(9):1065-74
    1. J Immunol. 1989 Nov 1;143(9):2961-8
    1. J Clin Invest. 1990 Jul;86(1):300-8
    1. J Histochem Cytochem. 1990 Aug;38(8):1179-86
    1. Science. 1990 Jul 13;249(4965):178-81
    1. Am J Respir Cell Mol Biol. 1991 Jan;4(1):26-32
    1. Biochem J. 1991 Jun 1;276 ( Pt 2):325-31
    1. Ann N Y Acad Sci. 1991;624:97-108
    1. Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 1):723-8

Source: PubMed

3
Abonnieren